Access to medicines and treatment: latest news

Access to medicines and treatment resources

Access to medicines and treatment features

Access to medicines and treatment news from aidsmap

More news

Access to medicines and treatment news selected from other sources

  • Here’s why I’m afraid—for the very first time in eight years of living with HIV

    For the first time in eight years of living with HIV, I’m afraid. That fear has very little to do with my infection, precisely. Over the years, I’ve realized how precariously my health is balanced on the access I have to affordable health care.

    20 hours ago | BETA blog
  • Liberia Way Behind in HIV Response, Kicks-off 'Catch-up' Plan

    UNAIDS' new Country Director, Ms. Miriam Chipimo, says she looks forward to contributing to the response of HIV prevalence in Liberia. Ms. Chipimo stated: “We haven’t reached most of the people around the country for testing; we have only reached 26 percent of those who are positive with the virus.” She also indicated that of the estimated 40,000 persons living with the virus throughout the country, 6,000 of them need treatment.

    18 May 2017 | Liberian Daily Observer
  • Costs for generic hepatitis C drugs available in India would be paid back in 5 to 10 years

    Use of the generic versions of directly-acting antiviral drugs that are available in India to treat hepatitis C virus infection is not only cost effective but actually saves lifetime costs for treating infected patients in that country.

    18 May 2017 | Eurekalert Inf Dis
  • United States: A GOP Health Care Plan May Ruin Our Best Chance At Ending HIV And AIDS

    Though it’s unclear how (or if) the ACA will be repealed, the plan passed by the House this month would certainly lead to fewer insured Americans and, by extension, fewer patients able to afford PrEP.

    17 May 2017 | Huffington Post
  • HIV Community Leaders Denounce Passage of American Health Care Act By U.S. House of Representatives

    On Thursday, May 4, the American Health Care Act (AHCA) passed the U.S. House of Representatives in a narrow vote. People living with HIV face distinct risks of life-threatening loss of health care if the AHCA is ultimately signed into law.

    05 May 2017 | The Body
  • India betrays people living with HIV by approving law that undermines right to life

    The HIV/AIDS (Prevention & Control) Bill was passed in the upper house of the Indian Parliament on 21 March 2017. The Bill states that the government will provide treatment for people living with HIV ‘as far as possible’ absolving the government from its responsibility to protect the right to life.

    03 May 2017 | International Treatment Preparedness Coalition (ITPC)
  • Louisiana proposes tapping a century-old patent law to cut hepatitis C drug prices

    Continuing public concerns over high-priced hepatitis C drugs are taking a new twist as Louisiana’s top health official proposes using an obscure federal patent law to get the medicines at a much lower cost. If successful, other states could reap the benefits.

    03 May 2017 | Washington Post
  • EMA and heads of national competent authorities discuss consequences of Brexit

    The European Medicines Agency (EMA) organised an information meeting yesterday with members of its Management Board and heads of the National Competent Authorities (NCAs) of the EU/EEA Member States. The goal was to start discussing how the work related to the evaluation and monitoring of medicines will be shared between Member States in view of the United Kingdom’s (UK) withdrawal from the European Union.

    02 May 2017 | EMA
  • New hepatitis data highlight need for urgent global response

    New WHO data reveal that an estimated 325 million people worldwide are living with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. The WHO Global hepatitis report, 2017 indicates that the large majority of these people lack access to life-saving testing and treatment. As a result, millions of people are at risk of a slow progression to chronic liver disease, cancer, and death.

    21 April 2017 | World Health Organization
  • The Medicines Patent Pool and Pharco Pharmaceuticals Sign Licence for Promising Hepatitis C Drug Candidate Ravidasvir

    The Medicines Patent Pool (MPP) announced a new licence and technology transfer agreement with Egyptian company Pharco Pharmaceuticals for ravidasvir (RAV), an investigational direct-acting antiviral (DAA) with the potential of working across all six major hepatitis C genotypes. The agreement, signed on the sidelines of the International Liver Congress in Amsterdam, will enable competitive supply of RAV in low- and middle-income countries (LMICs) including high prevalence nations Russia, Ukraine, Egypt and Iran.

    21 April 2017 | Medicines Patent Pool
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.